Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
09/2005
09/07/2005CN1217656C Method and pharmaceutical composition for regulating lipid concentration
09/06/2005US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
09/06/2005US6939895 Renalosteodystrophy comprising a compound, or a pharmaceutically acceptable salt or hydrate thereof, having the formula: Ar5-(CHR16)t-W-(CH2)u-CHR17)-NH-CH(R18)-Ar6 wherein: Ar5 is phenyl, indole, carbazole, pyridine,
09/06/2005US6939887 Nitrogen compounds such as 3-[2-(diethylamino)ethyl]-1-(2-methylbenzyl)-2-oxo-7-(trifluoromethyl)-2,3-dihydro-1H-benzimidazole-5-carboxamide trifluoroacetate, used as somatoliberins
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939880 Compounds with growth hormone releasing properties
09/05/2005CA2460602A1 Pancreatic multipotent progenitor cells
09/01/2005WO2005079780A1 Amidine derivatives for treating amyloidosis
09/01/2005US20050192449 chemical intermediates; for oral administration with improved absorption; antiestrogens; antitumor agents
09/01/2005US20050192335 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
09/01/2005US20050192259 A sustained release formulation of an aldosterone antagonist orally administered about 6-12 hours prior to the acrophase to provide a profile of plasma drug concentration corresponding to the diurnal cycle of plasma aldosterone concentration; hypotensive agents; circadi rhythm; cardiovascular disorders
09/01/2005US20050191650 Used to reduce body temperature, suppress appetite, and therapy or prophylaxis of congestive heart failure and various stress-related disorders
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005CA2556216A1 Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
09/01/2005CA2552094A1 Amidine derivatives for treating amyloidosis
08/2005
08/31/2005EP1568772A2 Human growth hormone variants
08/31/2005EP1568771A2 Human growth hormone variants
08/31/2005EP1568768A1 PROTEIN BINDING TO Akt2
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1567516A1 Method for the purification of liponic acid
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1066284B1 Benzo(c)quinolizine derivatives and their use as 5 alpha-reductases inhibitors
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662644A Method of producing human beta cell lines
08/31/2005CN1662549A Glucocorticoid receptor ligands for the treatment of metabolic disorders
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662538A Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662495A Acid-group-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662493A Ring -substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/31/2005CN1662241A Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
08/31/2005CN1662234A Use of thio-oxindole derivatives in treatment of hormone-related conditions
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660142A Refined extractive of cassah silkworm and preparation method
08/31/2005CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/31/2005CN1216859C Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups
08/30/2005US6936440 Selecting ligand agonists and antagonists
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/25/2005WO2005077968A2 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050186660 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
08/25/2005DE19833476B4 Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie Genetically modified CD34-negative adherently growing haematopoietic stem cells and their use in gene therapy
08/25/2005DE19540233B4 Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Containing sulphamate derivatives of 1,3,5 (10) -estratrien-derivatives, processes for their preparation and pharmaceutical compositions comprising these compounds
08/25/2005CA2556404A1 Nitrogenous fused heteroaromatic ring derivative
08/25/2005CA2552843A1 Steroids for cancer treatment
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1565197A1 Papaya puree and the use of the same
08/24/2005EP1565172A2 Suppression of cytotoxic protein conformers
08/24/2005EP1565171A2 Controlled absorption of mixed thyroyd hormone formulations
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1280779B1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
08/24/2005EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
08/24/2005EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
08/24/2005CN1659181A 9-alpha-substituted estratrienes as selectively active estrogens
08/24/2005CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases
08/24/2005CN1659157A Terphenyl derivatives, preparation thereof, compositions containing same
08/24/2005CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659144A Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
08/24/2005CN1659139A Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament
08/24/2005CN1658886A Hormone replacement therapy
08/24/2005CN1658885A Hormone replacement therapy
08/24/2005CN1658883A Methods for increasing the therapeutic response to electroconvulsive therapy
08/24/2005CN1658871A Amide derivatives as GK activators
08/24/2005CN1658868A Bazedoxifene treatment regimens
08/23/2005US6933321 For therapy of androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, precicious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness
08/23/2005US6933303 Antidiabetic agents
08/18/2005WO2005074896A1 Sustained release preparation
08/18/2005WO2003004608A3 Drug metabolizing enzymes
08/18/2005US20050182081 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
08/18/2005US20050182050 Therapeutic heterocyclic compounds
08/18/2005US20050182045 Fused ring 4-oxopyrimidine derivative
08/18/2005US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia
08/18/2005US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation
08/18/2005US20050181462 Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof
08/18/2005US20050181045 Vaginally administrable progesterone-containing tablets and method for preparing same
08/18/2005US20050181040 Progestagenic dosage unit
08/18/2005US20050180982 Assessing metastatic potential of carcinoma cells by contacting cells in tissue sample suspected of containing carcinoma with detectable indicator capable of binding to cad-11 or cad-11 mRNA and determining presence or absence of cad-11 expression in tissue; method of preventing or terminating pregnancy
08/18/2005DE102004003801A1 Recovering melanin from plant materials, for use e.g. in cancer treatment or as semiconductor, by extracting with sodium hydroxide solution, acidifying extract and purifying precipitate
08/18/2005CA2554262A1 Sustained-release preparations
08/18/2005CA2553899A1 Chemically-modified human growth hormone receptor antagonist conjugates
08/18/2005CA2553040A1 Modified human four helical bundle polypeptides and their uses
08/17/2005EP1562946A1 Novel xanthine derivatives, the production and the use thereof in the form of drugs
08/17/2005EP1562901A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
08/17/2005EP1562594A2 Methylene-bridged selective androgen receptor modulators and methods of use thereof
08/17/2005EP1427830A4 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
08/17/2005EP1289951B1 Growth hormone secretagogues
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 290